180 Life Sciences Corp (ATNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATNF | AMGN | VRTX | REGN | BMY |
| Company | 180 Life Sciences Corp | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.7000 | 314.63 | 434.59 | 978.27 | 44.47 |
| High | 1.7700 | 316.14 | 441.66 | 978.30 | 44.53 |
| Low | 1.4401 | 310.76 | 432.22 | 967.41 | 43.68 |
| Last | 1.6500 | 314.72 | 440.64 | 967.98 | 44.11 |
| Change | -0.2900 | -4.32 | +3.15 | -10.23 | -0.44 |
| % Change | -14.95% | -1.35% | +0.72% | -1.05% | -0.99% |
| Volume | 119,700 | 2,367,800 | 1,215,900 | 407,500 | 15,765,700 |
| 20-Day Average Volume | 29,225 | 2,981,265 | 1,120,365 | 461,860 | 14,696,805 |
| Previous Close | 1.9400 | 319.04 | 437.49 | 978.21 | 44.55 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9229 | 291.39 | 409.87 | 935.00 | 45.28 |
| 20-Day Raw Stochastic | 22.86% | 87.27% | 97.98% | 81.55% | 12.48% |
| 20-Day Relative Strength | 38.91% | 65.46% | 70.29% | 57.71% | 34.15% |
| Weighted Alpha | -93.72 | +40.22 | +31.27 | +28.22 | -34.11 |
| Today's Opinion | 100% Sell | 72% Buy | 72% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 88% Sell | 72% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 100% Sell | 56% Sell | 8% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -19.12% since 05/09/24 | +0.59% since 05/09/24 | +5.17% since 05/09/24 | unch since 05/09/24 | -1.41% since 05/09/24 |
| Low | 1.4401 on 05/16/24 | 307.06 on 05/13/24 | 417.50 on 05/10/24 | 966.34 on 05/15/24 | 43.68 on 05/16/24 |
| High | 2.1939 on 05/13/24 | 321.44 on 05/15/24 | 441.66 on 05/16/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | +11.49% since 04/16/24 | +18.48% since 04/16/24 | +11.79% since 04/16/24 | +8.26% since 04/16/24 | -8.60% since 04/16/24 |
| Low | 1.4401 on 05/16/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 2.3583 on 05/07/24 | 322.60 on 05/03/24 | 441.66 on 05/16/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | -57.70% since 02/16/24 | +10.93% since 02/16/24 | +4.37% since 02/16/24 | +2.10% since 02/16/24 | -11.53% since 02/16/24 |
| Low | 1.3300 on 04/16/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 4.7500 on 02/20/24 | 322.60 on 05/03/24 | 441.66 on 05/16/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -77.73% since 11/16/23 | +17.00% since 11/16/23 | +28.47% since 11/16/23 | +21.52% since 11/16/23 | -13.24% since 11/16/23 |
| Low | 1.3300 on 04/16/24 | 260.52 on 11/21/23 | 342.64 on 11/17/23 | 792.57 on 11/28/23 | 43.33 on 05/02/24 |
| High | 7.9325 on 11/17/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,654 | 171,144,224 | 112,895,608 | 107,785,040 | 90,307,296 |
| Shares Outstanding, K | 853 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -19,940,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -1,230,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.42 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.85 on 11/09/23 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.72 | 28.46 | 26.53 | 42.58 |